General Info
Philipp Mueller, a key member of the Boehringer Ingelheim Venture Fund team, has a strong focus on immuno-oncology and immuno-modulation investments. He serves on the board of ImCheck Therapeutics and Asgard Therapeutics, contributing to the fund’s portfolio in groundbreaking therapeutic potential in the field of anti-infectives. With a background in Molecular Biology and a PhD in Biochemistry, Philipp has extensive experience in translational immuno-oncology research and infectious diseases. He has built a global collaboration network with academic, biotech, and pharma partners, showing a hands-on partnership approach. Philipp’s career includes leading research and projects in Cancer Immunology and Immune Modulation within the pharmaceutical industry.
Location:
Country: Germany
Industries: Not available
Investment Regions: EU, NA
Investment Stages: pre-seed, seed
angel-individual
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Found Philipp Müller profile on Boehringer Ingelheim Venture Fund showing investments including SwitchKine (2024) and TECregen/Obulytix (2023). The most recent listed investment is SwitchKine in 2024, which is between 12 and 6 months before the reference date, corresponding to the ‘active’ category. The startup invested: SwitchKine (2024).
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Philipp Mueller
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI